Shalini John

1.1k total citations
28 papers, 799 citations indexed

About

Shalini John is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Shalini John has authored 28 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Computational Theory and Mathematics and 6 papers in Organic Chemistry. Recurrent topics in Shalini John's work include Computational Drug Discovery Methods (13 papers), Chemical Synthesis and Analysis (6 papers) and Histone Deacetylase Inhibitors Research (6 papers). Shalini John is often cited by papers focused on Computational Drug Discovery Methods (13 papers), Chemical Synthesis and Analysis (6 papers) and Histone Deacetylase Inhibitors Research (6 papers). Shalini John collaborates with scholars based in South Korea, United States and Iran. Shalini John's co-authors include Keun Woo Lee, Sundarapandian Thangapandian, Sugunadevi Sakkiah, Mahreen Arooj, Yong Jung Kwon, Yuno Lee, Kwang Dong Kim, Jong Chan Hong, Songmi Kim and Minky Son and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and BMC Bioinformatics.

In The Last Decade

Shalini John

28 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shalini John South Korea 17 524 356 186 131 115 28 799
Nanda Ghoshal India 18 534 1.0× 231 0.6× 221 1.2× 125 1.0× 127 1.1× 57 910
Matthew P. Baumgartner United States 9 564 1.1× 475 1.3× 142 0.8× 99 0.8× 60 0.5× 13 887
Marco Tutone Italy 21 595 1.1× 262 0.7× 257 1.4× 89 0.7× 128 1.1× 74 1.2k
Veronica Salmaso Italy 16 660 1.3× 319 0.9× 228 1.2× 77 0.6× 69 0.6× 50 1.0k
Temitope Isaac Adelusi Nigeria 16 427 0.8× 218 0.6× 166 0.9× 66 0.5× 74 0.6× 45 851
Philip Prathipati India 19 538 1.0× 304 0.9× 166 0.9× 90 0.7× 112 1.0× 34 998
Calvin Yu‐Chian Chen Taiwan 18 608 1.2× 370 1.0× 137 0.7× 163 1.2× 105 0.9× 72 1.1k
Sisheng Ouyang China 9 659 1.3× 403 1.1× 195 1.0× 161 1.2× 85 0.7× 10 1.1k
Minky Son South Korea 18 435 0.8× 215 0.6× 157 0.8× 108 0.8× 66 0.6× 40 744
Pascal Müller Switzerland 5 566 1.1× 510 1.4× 132 0.7× 113 0.9× 35 0.3× 8 780

Countries citing papers authored by Shalini John

Since Specialization
Citations

This map shows the geographic impact of Shalini John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shalini John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shalini John more than expected).

Fields of papers citing papers by Shalini John

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shalini John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shalini John. The network helps show where Shalini John may publish in the future.

Co-authorship network of co-authors of Shalini John

This figure shows the co-authorship network connecting the top 25 collaborators of Shalini John. A scholar is included among the top collaborators of Shalini John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shalini John. Shalini John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Son, Minky, Ayoung Baek, Sugunadevi Sakkiah, et al.. (2013). Exploration of Virtual Candidates for Human HMG-CoA Reductase Inhibitors Using Pharmacophore Modeling and Molecular Dynamics Simulations. PLoS ONE. 8(12). e83496–e83496. 21 indexed citations
2.
John, Shalini, et al.. (2013). New insights in the activation of human cholesterol esterase to design potent anti-cholesterol drugs. Molecular Diversity. 18(1). 119–131. 7 indexed citations
3.
Thangapandian, Sundarapandian, Shalini John, Mahreen Arooj, & Keun Woo Lee. (2012). Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design. PLoS ONE. 7(4). e34593–e34593. 18 indexed citations
4.
Thangapandian, Sundarapandian, et al.. (2012). Molecular Modeling Study on Tunnel Behavior in Different Histone Deacetylase Isoforms. PLoS ONE. 7(11). e49327–e49327. 26 indexed citations
5.
Arooj, Mahreen, et al.. (2012). Computational Studies of Novel Chymase Inhibitors Against Cardiovascular and Allergic Diseases: Mechanism and Inhibition. Chemical Biology & Drug Design. 80(6). 862–875. 4 indexed citations
6.
Thangapandian, Sundarapandian, Shalini John, & Keun Woo Lee. (2012). Molecular Dynamics Simulation Study Explaining Inhibitor Selectivity in Different Class of Histone Deacetylases. Journal of Biomolecular Structure and Dynamics. 29(4). 677–698. 26 indexed citations
7.
Thangapandian, Sundarapandian, et al.. (2012). Development of Predictive Quantitative Structure–Activity Relationship Model and Its Application in the Discovery of Human Leukotriene A4 Hydrolase Inhibitors. Future Medicinal Chemistry. 5(1). 27–40. 6 indexed citations
8.
John, Shalini, Sundarapandian Thangapandian, & Keun Woo Lee. (2012). Potential Human Cholesterol Esterase Inhibitor Design: Benefits from the Molecular Dynamics Simulations and Pharmacophore Modeling Studies. Journal of Biomolecular Structure and Dynamics. 29(5). 921–936. 9 indexed citations
9.
Thangapandian, Sundarapandian, et al.. (2012). Structural Origins for the Loss of Catalytic Activities of Bifunctional Human LTA4H Revealed through Molecular Dynamics Simulations. PLoS ONE. 7(7). e41063–e41063. 6 indexed citations
10.
Thangapandian, Sundarapandian, Shalini John, Sugunadevi Sakkiah, & Keun Woo Lee. (2011). Potential virtual lead identification in the discovery of renin inhibitors: Application of ligand and structure-based pharmacophore modeling approaches. European Journal of Medicinal Chemistry. 46(6). 2469–2476. 39 indexed citations
11.
Thangapandian, Sundarapandian, Shalini John, Sugunadevi Sakkiah, & Keun Woo Lee. (2011). Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors. European Journal of Medicinal Chemistry. 46(5). 1593–1603. 27 indexed citations
12.
John, Shalini, Sundarapandian Thangapandian, Mahreen Arooj, et al.. (2011). Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors. BMC Bioinformatics. 12(S14). S4–S4. 54 indexed citations
13.
Thangapandian, Sundarapandian, Shalini John, Sugunadevi Sakkiah, & Keun Woo Lee. (2011). Discovery of Potential Integrin VLA‐4 Antagonists Using Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies. Chemical Biology & Drug Design. 78(2). 289–300. 14 indexed citations
14.
Sakkiah, Sugunadevi, Sundarapandian Thangapandian, Shalini John, & Keun Woo Lee. (2011). Pharmacophore based virtual screening, molecular docking studies to design potent heat shock protein 90 inhibitors. European Journal of Medicinal Chemistry. 46(7). 2937–2947. 55 indexed citations
15.
Arooj, Mahreen, et al.. (2011). 3D QSAR Pharmacophore Modeling, in Silico Screening, and Density Functional Theory (DFT) Approaches for Identification of Human Chymase Inhibitors. International Journal of Molecular Sciences. 12(12). 9236–9264. 58 indexed citations
16.
John, Shalini, Sundarapandian Thangapandian, Sugunadevi Sakkiah, & Keun Woo Lee. (2010). Identification of potent virtual leads to design novel indoleamine 2,3-dioxygenase inhibitors: Pharmacophore modeling and molecular docking studies. European Journal of Medicinal Chemistry. 45(9). 4004–4012. 29 indexed citations
17.
Thangapandian, Sundarapandian, Shalini John, Sugunadevi Sakkiah, & Keun Woo Lee. (2010). Ligand and structure based pharmacophore modeling to facilitate novel histone deacetylase 8 inhibitor design. European Journal of Medicinal Chemistry. 45(10). 4409–4417. 77 indexed citations
18.
Sakkiah, Sugunadevi, Sundarapandian Thangapandian, Shalini John, Yong Jung Kwon, & Keun Woo Lee. (2010). 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors. European Journal of Medicinal Chemistry. 45(6). 2132–2140. 117 indexed citations
19.
Thangapandian, Sundarapandian, Shalini John, Sugunadevi Sakkiah, & Keun Woo Lee. (2010). Molecular Docking and Pharmacophore Filtering in the Discovery of Dual-Inhibitors for Human Leukotriene A4 Hydrolase and Leukotriene C4 Synthase. Journal of Chemical Information and Modeling. 51(1). 33–44. 32 indexed citations
20.
Sakkiah, Sugunadevi, Sundarapandian Thangapandian, Shalini John, & Keun Woo Lee. (2010). Identification of critical chemical features for Aurora kinase-B inhibitors using Hip-Hop, virtual screening and molecular docking. Journal of Molecular Structure. 985(1). 14–26. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026